{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:47:21Z","timestamp":1790858841898,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jiac.2021.01.019","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T09:34:47Z","timestamp":1613036087000},"page":"840-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["High mobility group box 1 and angiogenetic growth factor levels in children with central nerve system infections"],"prefix":"10.1016","volume":"27","author":[{"given":"Shinichiro","family":"Morichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kasuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soken","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Oana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyo","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.01.019_bib1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/341407","article-title":"Encephalitis and encephalopathy associated with influenza epidemic in Japan","volume":"35","author":"Morishima","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.01.019_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virusres.2004.02.016","article-title":"Influenza-associated acute encephalopathy in Japanese children in 1994-2002","volume":"103","author":"Togashi","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.jiac.2021.01.019_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.50.2.407","article-title":"Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis\/encephalopathy","volume":"50","author":"Ichiyama","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jiac.2021.01.019_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jiac.2021.01.019_bib5","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar3450","article-title":"High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts","volume":"13","author":"W\u00e4h\u00e4maa","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.jiac.2021.01.019_bib6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1440-1789.2012.01310.x","article-title":"TLR4, IL-6, IL-18, MyD88 and HMGB1 are highly expressed in intracranial inflammatory lesions and the IgG4\/IgG ratio correlates with TLR4 and IL-6","volume":"32","author":"Hirano","year":"2012","journal-title":"Neuropathology"},{"key":"10.1016\/j.jiac.2021.01.019_bib7","first-page":"101","article-title":"Emerging roles for HMGB1 protein in immunity, inflammation, and cancer","volume":"4","author":"Martinotti","year":"2015","journal-title":"ImmunoTargets Ther"},{"issue":"5","key":"10.1016\/j.jiac.2021.01.019_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.jcbfm.9600582","article-title":"Early release of HMGB-1 from neurons after the onset of brain ischemia","volume":"28","author":"Qiu","year":"2008","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.jiac.2021.01.019_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0404.2007.00809.x","article-title":"Acute encephalopathy associated with influenza and other viral infections","volume":"186","author":"Mizuguchi","year":"2007","journal-title":"Acta Neurol Scand Suppl"},{"issue":"1","key":"10.1016\/j.jiac.2021.01.019_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/SHK.0b013e3181997173","article-title":"HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans","volume":"32","author":"Peltz","year":"2009","journal-title":"Shock"},{"issue":"7","key":"10.1016\/j.jiac.2021.01.019_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ajh.21732","article-title":"Normal ranges of angiogenesis regulatory proteins in human platelets","volume":"85","author":"Peterson","year":"2010","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jiac.2021.01.019_bib12","doi-asserted-by":"crossref","first-page":"17842","DOI":"10.1038\/s41598-017-17865-2","article-title":"Cytokine profiling in healthy children shows association of age with cytokine concentrations","volume":"7","author":"Decker","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jiac.2021.01.019_bib13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.autrev.2012.03.007","article-title":"HMGB1 in vascular diseases: its role in vascular inflammation and atherosclerosis","volume":"11","author":"de Souza","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.jiac.2021.01.019_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/03009740802144143","article-title":"High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease","volume":"37","author":"Hoshina","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.jiac.2021.01.019_bib15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00431-014-2327-1","article-title":"High-mobility group box 1 (HMGB1) in childhood: from bench to bedside","volume":"173","author":"Chirico","year":"2014","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.jiac.2021.01.019_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cyto.2011.07.016","article-title":"Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children","volume":"56","author":"Ito","year":"2011","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.jiac.2021.01.019_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.braindev.2013.07.001","article-title":"High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy","volume":"36","author":"Momonaka","year":"2014","journal-title":"Brain Dev"},{"issue":"1\u20132","key":"10.1016\/j.jiac.2021.01.019_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jns.2010.07.018","article-title":"Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome","volume":"298","author":"Yamanaka","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"issue":"9","key":"10.1016\/j.jiac.2021.01.019_bib19","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1161\/STROKEAHA.110.590463","article-title":"High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia","volume":"41","author":"Qiu","year":"2010","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jiac.2021.01.019_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/INF.0b013e31803994a0","article-title":"Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy","volume":"26","author":"Ichiyama","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jiac.2021.01.019_bib21","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/STROKEAHA.110.598334","article-title":"Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats","volume":"42","author":"Zhang","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jiac.2021.01.019_bib22","first-page":"299","article-title":"Cerebrospinal fluid NOx (nitrite\/nitrate) in RSV-infected children with CNS symptoms","volume":"59","author":"Morichi","year":"2009","journal-title":"J\u00a0Infect"},{"issue":"2","key":"10.1016\/j.jiac.2021.01.019_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jiac.2016.10.007","article-title":"Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) levels in the cerebrospinal fluid of children with influenza-associated encephalopathy","volume":"23","author":"Morichi","year":"2017","journal-title":"J\u00a0Infect Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2021.01.019_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00401-002-0605-x","article-title":"Apoptosis and microglial activation in influenza encephalopathy","volume":"105","author":"Nakai","year":"2003","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.jiac.2021.01.019_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/00207454.2011.580868","article-title":"High mobility group box 1 in cerebrospinal fluid from several neurological diseases at early time points","volume":"121","author":"Asano","year":"2011","journal-title":"Int J Neurosci"},{"issue":"5","key":"10.1016\/j.jiac.2021.01.019_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1155\/2013\/327604","article-title":"Brain hypothermic therapy dramatically decreases elevated blood concentrations of high mobility group box 1 in neonates with hypoxic-ischemic encephalopathy","volume":"35","author":"Nakamura","year":"2013","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.jiac.2021.01.019_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jphs.2019.04.006","article-title":"Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases","volume":"140","author":"Nishibori","year":"2019","journal-title":"J\u00a0Pharmacol Sci"},{"issue":"1\u20133","key":"10.1016\/j.jiac.2021.01.019_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2009.09.010","article-title":"Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay","volume":"623","author":"Wake","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jiac.2021.01.019_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.CCM.0000295316.86942.CE","article-title":"A\u00a0pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis","volume":"36","author":"Tang","year":"2008","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jiac.2021.01.019_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/317643","article-title":"Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain","volume":"183","author":"van der Flier","year":"2001","journal-title":"J\u00a0Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:01:04Z","timestamp":1761159664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1341321X21000313"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.01.019","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High mobility group box 1 and angiogenetic growth factor levels in children with central nerve system infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}